Showing results (121-130 of 160) with videos related to
Sort By:
Pageof 16
Journal of the National Cancer Institute|May 15, 2020
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040Kevin J Harrington, Denis Soulières, Christophe Le Tourneau, et al.Journal of the National Cancer Institute|June 26, 2023
The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadershipRebecca A Snyder, Barbara Burtness, May Cho, et al.Cephalalgia : an International Journal of Headache|May 1, 2015
Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraineTony W Ho, Andrew P Ho, Yang Joy Ge, et al.European Journal of Cancer (Oxford, England : 1990)|April 22, 2025
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 studyMakoto Tahara, Richard Greil, Danny Rischin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2025
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III StudyJean Bourhis, Lisa F Licitra, Barbara Burtness, et al.British Journal of Cancer|June 30, 2018
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012Ranee Mehra, Tanguy Y Seiwert, Shilpa Gupta, et al.Future Oncology (London, England)|October 15, 2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumorsThomas Powles, Aarti Bhatia, Barbara Burtness, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2022
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 StudyKevin J Harrington, Barbara Burtness, Richard Greil, et al.International Journal of Radiation Oncology, Biology, Physics|November 21, 2022
Outcomes Stratification of Head and Neck Cancer Using Pre- and Post-treatment DNA Methylation From Peripheral BloodDavid C Qian, Bryan C Ulrich, Gang Peng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2021
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311)Robert L Ferris, Yael Flamand, Gregory S Weinstein, et al.Pageof 16